This is the first European study to show a safe screening interval of 9 years with messenger RNA (mRNA) human papillomavirus (HPV) Aptima testing with a 99.9% negative predictive value. REINA study d…
The FIBI technology, created by Farzad Fereidouni, PhD, when combined with AI eliminates the need for frozen sections and other labor-intensive oncology surgery practices.
Researchers compared responses from ChatGPT on colon cancer with expert opinion from oncology clinicians.
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
In case you missed any, read a recap of the episodes of OncLive On Air that aired in January 2025.
The association of CAR T-cell therapies with second primary cancers warrants the development and examination of mitigation strategies for these toxic effects.
CARGO Therapeutics announced that it will discontinue the phase 2 FIRCE-1 trial evaluating firi-cel in relapsed/refractory large B-cell lymphoma.
Compared with standard tyrosine kinase inhibitors, asciminib demonstrated improved safety and tolerability for the treatment of chronic myeloid leukemia, according to phase 3 data presented…
Immunotherapy stands as one of the most transformative breakthroughs in modern cancer treatment. These innovative therapies target signaling pathways used by cancer cells to induce…
OQY-3258 (ESG401) showed preliminary efficacy in multiple breast cancer subtypes, including TNBC and HR+/HER2- breast cancer.
